Minimally invasive surgical approaches offer earlier time to adjuvant chemotherapy but not improved survival in resected pancreatic cancer

被引：0
|
作者：
Katelin A. Mirkin
Erin K. Greenleaf
Christopher S. Hollenbeak
Joyce Wong
机构：
[1] The Pennsylvania State University,Division of Surgical Oncology, Department of Surgery, College of Medicine
[2] The Pennsylvania State University,Department of Public Health Sciences, College of Medicine
来源：
Surgical Endoscopy | 2018年 / 32卷
关键词：
Pancreatic cancer; Minimally invasive surgery; MIS; Time to adjuvant therapy; NCDB;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：2387 / 2396
页数：9
相关论文
共 50 条
  • [31] Timeliness of adjuvant chemotherapy in patients with resected pancreatic cancer.
    Deng, David
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Interpretation the Results of Adjuvant Chemotherapy in Curatively Resected Pancreatic Cancer
    Chen, Li-Tzong
    ANNALS OF ONCOLOGY, 2019, 30 : 78 - 78
  • [33] Adjuvant Radiotherapy and Chemotherapy Offer a Recurrence and Survival Benefit in Patients with Resected Perihilar Cholangiocarcinoma
    Im, J. H.
    Choi, G. H.
    Lee, W. J.
    Han, D. H.
    Park, S. W.
    Bang, S. M.
    Choi, H. J.
    Seong, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E221 - E222
  • [34] ADJUVANT CHEMOTHERAPY AFTER MINIMALLY INVASIVE SURGERY FOR COLON AND RECTAL CANCER - ARE WE MISSING THE OPPORTUNITY FOR EARLIER THERAPY?
    Norcross, L.
    Ferrara, A.
    Williamson, P.
    Kayaleh, O.
    DeJesus, S.
    Mueller, R.
    Gallagher, J.
    DISEASES OF THE COLON & RECTUM, 2009, 52 (04) : 837 - 837
  • [35] Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?
    Zaheer S. Kanji
    Alicia M. Edwards
    Margaret T. Mandelson
    Nadav Sahar
    Bruce S. Lin
    Kasra Badiozamani
    Guobin Song
    Adnan Alseidi
    Thomas R. Biehl
    Richard A. Kozarek
    William S. Helton
    Vincent J. Picozzi
    Flavio G. Rocha
    Annals of Surgical Oncology, 2018, 25 : 1052 - 1060
  • [36] Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?
    Kanji, Zaheer S.
    Edwards, Alicia M.
    Mandelson, Margaret T.
    Sahar, Nadav
    Lin, Bruce S.
    Badiozamani, Kasra
    Song, Guobin
    Alseidi, Adnan
    Biehl, Thomas R.
    Kozarek, Richard A.
    Helton, William S.
    Picozzi, Vincent J.
    Rocha, Flavio G.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 1052 - 1060
  • [37] Improved Overall Survival With Adjuvant Radiation on Resected Pancreatic Tail Adenocarcinoma
    Frakes, J. M.
    Shridhar, R.
    Strom, T.
    Venkat, P. S.
    Springett, G. M.
    Hodul, P. J.
    Pimiento, J. M.
    Meredith, K.
    Malafa, M. P.
    Hoffe, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E128 - E129
  • [38] Minimally Invasive Surgical Approaches for Pancreatic Adenocarcinoma: Recent Trends
    Lianos G.D.
    Christodoulou D.K.
    Katsanos K.H.
    Katsios C.
    Glantzounis G.K.
    Journal of Gastrointestinal Cancer, 2017, 48 (2) : 129 - 134
  • [39] Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer
    Erin K. Greenleaf
    Afif N. Kulaylat
    Christopher S. Hollenbeak
    Khaldoun Almhanna
    Joyce Wong
    Annals of Surgical Oncology, 2016, 23 : 4203 - 4213
  • [40] Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer
    Greenleaf, Erin K.
    Kulaylat, Afif N.
    Hollenbeak, Christopher S.
    Almhanna, Khaldoun
    Wong, Joyce
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (13) : 4203 - 4213
12345